The rate of cardiac injury as determined by cTnI in this study was 19%. In trying to identify any factors that may contribute to an overestimation of cardiac injury, we consider the use of cTnI ...

The researchers have designed a paper-based vertical flow assay (VFA). It detects cardiac troponin I (cTnI), a protein ...

It provides cTnI results in just 25 min for rapid clinical decision-making. "This technology represents a major step toward democratizing high-quality cardiac diagnostics," said Professor Ozcan.

The following is a summary of "Macrotroponin interference and association with cardiotoxicity in patients receiving cardiotoxic breast cancer therapy: a pilot study," published in the February 2025 ...

To address this disease burden, Abbott developed a cardiac-specific biomarker, high-sensitivity cardiac troponin I (hs-cTnI), to help doctors more accurately predict the chances of a heart attack ...

One hundred and four patients (67%) were male. Elevated cTnI levels were found in 30 (19%) patients (Group B). One hundred and twenty-six (81%) patients had normal cTnI levels (Group A).